Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
J Pain Symptom Manage. 2019 Jun;57(6):1062-1070. doi: 10.1016/j.jpainsymman.2019.02.023. Epub 2019 Mar 1.
With increasing attention to the undertreatment of cancer pain in parallel with concerns about opioid misuse, little is known about how patients with advanced cancer adhere to opioid regimens for chronic cancer pain.
We explored patient approaches to managing chronic cancer pain with long-acting opioids.
In a multimethods study at an academic medical center, adult patients with chronic cancer pain (n = 17) used electronic pill caps to record adherence to prescribed long-acting opioid regimens. After eight weeks, patients viewed their adherence records and completed a semistructured interview about their opioid use. With a framework approach, we coded interview data (Kappa >0.95) and identified themes in how patients perceived and used opioids to manage cancer pain.
Patients (59% female; 94% non-Hispanic white; median age = 65 years) felt grateful about pain benefit from opioids yet concerned about opioid side effects and addiction/tolerance. Main reasons for nonadherence included both intentional decisions (e.g., skipping doses) and unintentional barriers (e.g., missing doses due to inconsistent sleep schedules). Overall, patients set their own opioid adherence goals and developed routines to achieve them. Residual pain varied and was not consistently linked with opioid adherence.
Patients commonly felt conflicted about using prescribed long-acting opioids to manage cancer pain due to concurrent perceptions of their risks and benefits, and they set their own parameters for opioid-taking practices. Intentional and unintentional deviations from prescribed opioid schedules highlight the need to enhance adherence communication, education, and counseling, to optimize the use of long-acting opioids as a component of cancer pain management.
随着人们越来越关注癌症疼痛治疗不足的问题,同时也对阿片类药物滥用感到担忧,但对于晚期癌症患者如何坚持使用长效阿片类药物治疗慢性癌症疼痛知之甚少。
我们探讨了患者管理慢性癌症疼痛的方法,使用长效阿片类药物。
在一家学术医疗中心进行的多方法研究中,慢性癌症疼痛患者(n=17)使用电子药盒记录规定的长效阿片类药物方案的依从性。八周后,患者查看他们的用药记录并完成关于他们阿片类药物使用的半结构式访谈。采用框架方法,我们对访谈数据进行编码(Kappa >0.95),并确定了患者感知和使用阿片类药物治疗癌症疼痛的主题。
患者(59%为女性;94%为非西班牙裔白人;中位年龄 65 岁)对阿片类药物缓解疼痛感到感激,但对阿片类药物的副作用和成瘾/耐受感到担忧。不依从的主要原因包括有意决定(例如,跳过剂量)和无意障碍(例如,由于不规律的睡眠时间而错过剂量)。总的来说,患者设定了自己的阿片类药物依从性目标,并制定了实现这些目标的常规。残留疼痛存在差异,与阿片类药物的依从性没有一致的联系。
患者由于同时考虑到使用处方长效阿片类药物治疗癌症疼痛的风险和益处,常常感到矛盾,他们为自己的阿片类药物使用习惯设定了自己的参数。有意和无意地偏离规定的阿片类药物方案突出表明,需要加强对阿片类药物依从性的沟通、教育和咨询,以优化长效阿片类药物作为癌症疼痛管理的一部分的使用。